NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Prothena Corporation plc Ordinary Shares Share Price Chart

O H L

Prothena Corporation plc Ordinary Shares Performance Overview

Days Range
$8.40Low
$8.40High

Markets Today

Previous Close$8.24
Open$8.40
Volume90,397
Day's Range$8.40 - $8.40
52W Range$7.73 - $11.80
Market Cap$427.64 M

Historical Performance

1M Returns-7.21
3M Returns-2.94
6M Returns-8.44
1Y Returns+2.23
5Y Returns-89.31
10Y Returns-86.51

Prothena Corporation plc Ordinary Shares Fundamentals

Market Cap$427.64 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$9.68 M
ROE TTM-0.64
EPS TTM$-0.83
Quarterly Earnings Growth YOYN/A
PB Ratio1.50
EBITDA$-183.66 M
Profit Margin-2520.57
Market Cap$427.64 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$9.68 M
ROE TTM-0.64
EPS TTM$-0.83
Quarterly Earnings Growth YOYN/A
PB Ratio1.50
EBITDA$-183.66 M
Profit Margin-2520.57

Prothena Corporation plc Ordinary Shares Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$2.83 M$4.42 M$2.42 M$21.00 K$51.08 M$1.01 M
Gross Profit +$2.83 M$4.42 M$2.42 M$21.00 K$51.08 M$1.01 M
Operating Income -$65.58 M-$84.62 M-$40.24 M-$24.20 M$30.04 M-$21.10 M
EBITDA -$65.36 M-$51.78 M-$39.53 M-$26.99 M$25.98 M-$18.49 M
Interest Expense $0$0$3.35 M$2.65 M$0$0
Depreciation $223.00 K$32.83 M$706.00 K-$2.79 M-$4.06 M$2.61 M
Income Before Tax -$61.37 M-$80.97 M-$36.91 M-$21.58 M$32.72 M-$18.58 M
Income Tax Expense -$1.18 M$44.80 M-$371.00 K$10.00 K$1.00 K$2.00 K
Net Income +-$60.20 M-$125.77 M-$36.54 M-$21.59 M$32.72 M-$18.58 M
Net Profit Margin -2128.54%-2845.41%-1513.08%-102804.76%64.05%-1839.9%

Prothena Corporation plc Ordinary Shares Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $538.00 K$538.00 K$538.00 K$538.00 K$530.00 K$517.00 K
Reserve & Surplus -$1.16 B-$1.29 B-$1.32 B-$1.35 B-$1.31 B-$1.33 B
Non-Current Liabilities $9.20 M$6.93 M$6.20 M$5.49 M$4.76 M$4.03 M
Current Liabilities $48.46 M$67.81 M$51.44 M$40.84 M$32.52 M$11.66 M
Total Liabilities $57.66 M$74.73 M$57.64 M$46.33 M$37.28 M$15.69 M
Fixed Assets $2.87 M$2.69 M$2.46 M$2.14 M$1.96 M$2.49 M
Current Assets $436.17 M$385.48 M$339.97 M$315.19 M$339.20 M$292.01 M
Total Assets $495.34 M$399.07 M$352.63 M$326.80 M$349.89 M$302.58 M

Prothena Corporation plc Ordinary Shares Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$60.20 M-$125.77 M-$36.54 M-$21.59 M$32.72 M-$18.58 M
Operating Cash Flow -$53.36 M-$46.34 M-$40.56 M-$23.31 M$28.88 M-$25.05 M
Investing Cash Flow -$42.00 K-$86.00 K-$10.00 K$0$0-$652.00 K
Financing Cash Flow -$48.00 K-$74.00 K-$17.00 K$0-$6.95 M-$15.57 M
Change in Cash -$53.45 M-$46.50 M-$40.59 M-$23.31 M$21.93 M-$41.27 M

Prothena Corporation plc Ordinary Shares Return Calculator

The Prothena Corporation plc Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,100
Invested Amount$10,000
Est. Returns$-8,900
Invest in USA Stock Today

About Prothena Corporation plc Ordinary Shares

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

FAQs

Prothena Corporation plc Ordinary Shares (PRTA) share price as of September 17, 2026 is $8.48. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Prothena Corporation plc Ordinary Shares (PRTA) Share by opening an international trading account with Angel One.
Purchasing Prothena Corporation plc Ordinary Shares (PRTA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Prothena Corporation plc Ordinary Shares (PRTA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Prothena Corporation plc Ordinary Shares (PRTA) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Prothena Corporation plc Ordinary Shares on September 17, 2026, is $427.64 M.
Prothena Corporation plc Ordinary Shares operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Prothena Corporation plc Ordinary Shares (PRTA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91